Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 13 | 2023 | 535 | 1.180 |
Why?
|
| Breast Neoplasms | 19 | 2023 | 2903 | 1.110 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2023 | 10 | 0.950 |
Why?
|
| Ovarian Neoplasms | 7 | 2023 | 744 | 0.890 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2021 | 8 | 0.810 |
Why?
|
| RNA Helicases | 1 | 2021 | 35 | 0.780 |
Why?
|
| Genes, BRCA2 | 13 | 2023 | 160 | 0.770 |
Why?
|
| Genes, BRCA1 | 11 | 2012 | 192 | 0.670 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 408 | 0.640 |
Why?
|
| Genetic Counseling | 5 | 2021 | 100 | 0.550 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1208 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2023 | 2271 | 0.490 |
Why?
|
| Community Participation | 1 | 2012 | 36 | 0.440 |
Why?
|
| Awareness | 1 | 2012 | 93 | 0.420 |
Why?
|
| Mutation | 11 | 2021 | 3968 | 0.400 |
Why?
|
| Germ-Line Mutation | 4 | 2022 | 329 | 0.310 |
Why?
|
| BRCA1 Protein | 3 | 2023 | 200 | 0.270 |
Why?
|
| Genetic Carrier Screening | 2 | 2008 | 60 | 0.240 |
Why?
|
| BRCA2 Protein | 2 | 2014 | 158 | 0.230 |
Why?
|
| Female | 24 | 2023 | 44534 | 0.230 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2023 | 128 | 0.220 |
Why?
|
| Genital Neoplasms, Female | 1 | 2023 | 107 | 0.200 |
Why?
|
| Counselors | 1 | 2021 | 2 | 0.200 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2021 | 10 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 108 | 0.200 |
Why?
|
| Health Equity | 1 | 2023 | 77 | 0.190 |
Why?
|
| Mammography | 2 | 2006 | 463 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 549 | 0.180 |
Why?
|
| Humans | 28 | 2023 | 86645 | 0.180 |
Why?
|
| Complementary Therapies | 1 | 2020 | 54 | 0.170 |
Why?
|
| Breast Neoplasms, Male | 2 | 2014 | 30 | 0.170 |
Why?
|
| Middle Aged | 14 | 2023 | 25028 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 394 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 279 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2021 | 2262 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 645 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 1204 | 0.140 |
Why?
|
| Phenotype | 1 | 2023 | 2378 | 0.140 |
Why?
|
| Aged | 9 | 2021 | 18415 | 0.120 |
Why?
|
| Ovariectomy | 3 | 2009 | 81 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 938 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2022 | 8491 | 0.100 |
Why?
|
| Parent-Child Relations | 2 | 2009 | 77 | 0.090 |
Why?
|
| Adult | 14 | 2021 | 25648 | 0.090 |
Why?
|
| Adult Children | 1 | 2009 | 12 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 696 | 0.090 |
Why?
|
| Heterozygote | 2 | 2008 | 365 | 0.090 |
Why?
|
| Systems Integration | 1 | 2008 | 35 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2008 | 41 | 0.080 |
Why?
|
| Truth Disclosure | 1 | 2009 | 87 | 0.080 |
Why?
|
| Infertility | 1 | 2008 | 37 | 0.080 |
Why?
|
| Fallopian Tubes | 1 | 2008 | 41 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 120 | 0.080 |
Why?
|
| Health Behavior | 3 | 2020 | 183 | 0.080 |
Why?
|
| Bilirubin | 1 | 2007 | 125 | 0.070 |
Why?
|
| Preimplantation Diagnosis | 1 | 2006 | 5 | 0.070 |
Why?
|
| Disclosure | 1 | 2007 | 108 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2006 | 15 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2006 | 89 | 0.070 |
Why?
|
| Glucuronosyltransferase | 1 | 2007 | 184 | 0.070 |
Why?
|
| Risk Factors | 4 | 2021 | 5417 | 0.070 |
Why?
|
| Mastectomy | 1 | 2008 | 243 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2006 | 218 | 0.070 |
Why?
|
| Prevalence | 2 | 2023 | 1239 | 0.060 |
Why?
|
| Computational Biology | 1 | 2008 | 528 | 0.060 |
Why?
|
| Male | 7 | 2021 | 40967 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 819 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2014 | 2767 | 0.050 |
Why?
|
| Europe | 1 | 2023 | 309 | 0.050 |
Why?
|
| Disease Progression | 1 | 2006 | 1531 | 0.050 |
Why?
|
| Ohio | 1 | 2021 | 37 | 0.050 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2021 | 18 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 51 | 0.050 |
Why?
|
| ROC Curve | 1 | 2002 | 752 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2006 | 730 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6509 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1565 | 0.040 |
Why?
|
| Pedigree | 3 | 2008 | 966 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2002 | 1078 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 4213 | 0.040 |
Why?
|
| Diet | 1 | 2020 | 443 | 0.040 |
Why?
|
| Exercise | 1 | 2020 | 315 | 0.040 |
Why?
|
| Data Collection | 2 | 2008 | 372 | 0.030 |
Why?
|
| Adolescent | 4 | 2009 | 8982 | 0.030 |
Why?
|
| Family Health | 2 | 2009 | 162 | 0.030 |
Why?
|
| Neoplasms | 2 | 2008 | 2898 | 0.030 |
Why?
|
| Algorithms | 1 | 2002 | 1830 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2014 | 13 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 5976 | 0.030 |
Why?
|
| Probability | 2 | 2005 | 355 | 0.030 |
Why?
|
| Chicago | 2 | 2009 | 1379 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 265 | 0.030 |
Why?
|
| Online Systems | 1 | 2008 | 24 | 0.020 |
Why?
|
| Fertility Agents, Female | 1 | 2008 | 4 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2008 | 12 | 0.020 |
Why?
|
| Menotropins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Clomiphene | 1 | 2008 | 18 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 157 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 69 | 0.020 |
Why?
|
| Minority Groups | 1 | 2009 | 137 | 0.020 |
Why?
|
| Dinucleotide Repeats | 1 | 2007 | 13 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 98 | 0.020 |
Why?
|
| Estrogens | 1 | 2008 | 200 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 185 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2008 | 319 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2006 | 28 | 0.020 |
Why?
|
| Public Policy | 1 | 2006 | 52 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 473 | 0.020 |
Why?
|
| Syndrome | 1 | 2006 | 446 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2006 | 278 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 238 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 999 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 677 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 642 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2008 | 814 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 567 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1805 | 0.010 |
Why?
|
| United States | 2 | 2006 | 6674 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 1851 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 575 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 556 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1187 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 293 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3680 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 2501 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 526 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 2357 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1991 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1673 | 0.010 |
Why?
|
| Child | 1 | 2007 | 6928 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 1294 | 0.010 |
Why?
|